Healwell's Darwen AI to match clinical trials to 100K+ consented patients
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
September 8, 2026 6:32 AM EDTHEALWELL's DARWEN" AI platform is used to connect WELLTRUST" patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching trial protocols against the consented patient population. WELLTRUST", a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. Patient consents are captured and managed using OceanMD, WELLSTAR's patient engagement platform, which presents the WELLTRUST" consent within the digital check-in workflow... More
